Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas

Cancer Letters

Volumn 86, Issue 2, 1994, Pages 215-221

  Finnegan, M C M ^a   Goepel, J R ^a   Royds, J ^a   Hancock, B W ^a   Goyns, M H ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

MDM 2; Non Hodgkins's lymphoma; p53

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DENSITOMETRY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID HYPERPLASIA; NONHODGKIN LYMPHOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN STABILITY;

BLOTTING, NORTHERN; HUMAN; LYMPH NODES; LYMPHOMA, NON-HODGKIN; PROTEIN P53; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TONSIL;

EID: 0028007535     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(94)90081-7     Document Type: Article

References (25)

1. p53 mutations in human cancer
2. The p53 tumor suppressor gene
3. Detection of a transformation related antigen in chemically induced sarcomas and other transformed cells of the mouse
4. T antigen is bound to a host protein in SV40-transformed cells
5. Characterisation of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
6. Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.
7. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology and exposure to cytotoxic treatment
8. Cytogenetic analysis of a United Kingdom series of non-Hodgkin's lymphomas
9. P53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
10. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma
11. Analysis of the p53 gene, its expression and protein stabilization in non-Hodgkin's lymphomas
12. P53 expression in lymphatic malignancies
13. P53 protein expression in lymphomas and reactive node tissue
14. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations
15. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest
16. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
17. Amplification of a gene encoding a p53-associated protein in human sarcomas
18. Updated Kiel classification for lymphomas
19. Single step method of RNA isolation by acid guanidinium thiocyanatephenol chloroform extraction
20. Investigation of the expression of housekeeping genes in non-Hodgkin's lymphomas
21. Interphase cytogenetic analysis of non-Hodgkin's lymphoma
22. Upregulation of mdm-2 expression in meth A tumor cells tolerating wild-type p53
23. The p53-mdm2 autoregulatory feedback loop
24. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth